October 13, 2022 02:20 PM EDT
Pharma

No­var­tis to cut up to 400 jobs at Dublin cam­pus

Nicole DeFeudis

Editor

Weeks af­ter CEO Vas Narasimhan un­veiled a “US-first” strat­e­gy in re­shap­ing No­var­tis, the Swiss phar­ma gi­ant has re­vealed plans to cut around 400 jobs at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J's new can­cer com­bo beats As­traZeneca's Tagris­so on sur­vival in lung tri­al

FDA sets an ef­fi­ca­cy thresh­old for fu­ture weight loss drugs

Sanofi part­ners with Al­loy Ther­a­peu­tics to make new CNS drug

Cal­i­co, De­nal­i's ALS drugs miss pri­ma­ry ob­jec­tives in bas­ket study

Maze files for first biotech IPO of 2025, fol­low­ing $115M fund­ing boost

Ver­tex signs in vi­vo gene edit­ing de­liv­ery pact for sick­le cell and tha­lassemia as it looks be­yond Cas­gevy

A service from the Financial Times